Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus Nucleoprotein

The urgent need for vaccines against Ebola virus (EBOV) was underscored by the large outbreak in West Africa (2014–2016). Since then, several promising vaccine candidates have been tested in pre-clinical and clinical studies. As a result, two vaccines were approved for human use in 2019/2020, of whi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kupke, Alexandra, Volz, Asisa, Dietzel, Erik, Freudenstein, Astrid, Schmidt, Jörg, Shams-Eldin, Hosam, Jany, Sylvia, Sauerhering, Lucie, Krähling, Verena, Gellhorn Serra, Michelle, Herden, Christiane, Eickmann, Markus, Becker, Stephan, Sutter, Gerd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027530/
https://www.ncbi.nlm.nih.gov/pubmed/35455282
http://dx.doi.org/10.3390/vaccines10040533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027530/
https://www.ncbi.nlm.nih.gov/pubmed/35455282
http://dx.doi.org/10.3390/vaccines10040533

Ejemplares similares